Early Detection Research Network

Biomarkers: the key to early detection

You are here: Home › Protocols › Clinical Validation of Molecular Signatures of Cervical Neoplasia

Abbreviated Name: Clinical Validation of Molecular Signatures of Cervical Neoplasia

Protocol ID: 60

Lead Investigator: Unger, Elizabeth R. — Centers for Disease Control

Coordinating Investigator: Unger, Elizabeth R. — Centers for Disease Control

Involved Investigator Sites:

Biomarker Name:

Design: Case/control

Field(s) of Research: UNKNOWN

Collaborative Group Text: Breast and Gynecologic Cancers Research

Phased Status:

Description:

Abstract:

Aims:

Analytic Method:

Comments:

Biomarkers:

There are currently no biomarkers annotated for this protocol.

Datasets:

No datasets are currently associated with this protocol.